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ABSTRACT 
Objective: Trichuriasis is difficult to treat with single-dose anthelmintic. Although a higher cure rate (CR) can be achieved by treatment with triple-
dose albendazole and mebendazole, the results of studies are inconsistent. This study aimed to evaluate the effectiveness of triple-dose albendazole 
and mebendazole in treating trichuriasis.  
Methods: A randomized controlled trial was conducted in a primary school in the Pandeglang District, Banten Province, Indonesia in July–August, 
2018; 382 children were recruited. Stools were collected and examined microscopically using the Kato–Katz method to identify Trichuriasis eggs. 
Children positive for Trichuris trichiura were randomized and divided into two groups. One was given a triple dose of 400 mg albendazole and the 
other a triple dose of 500 mg mebendazole. On day 14 after treatment, stools were reexamined to calculate CR and the egg reduction rate (ERR). 
Data were analyzed using SPSS version 20.  
Results: The prevalence of soil-transmitted helminth infection was 42%, and that of trichuriasis and ascariasis was 25.1% and 29.8%. There was a 
significant difference (Wilcoxon test, P<0.01) in the intensity of infection before and after intervention. Both groups showed high values of CR 
(mebendazole: 95.2%, albendazole: 85.4%; Fisher’s exact test, P = 0.125) and ERR (mebendazole: 99%, albendazole: 96%; Mann–Whitney test, P = 
0.110). There was no significant difference in CR and ERR between the two groups.  
Conclusion: Triple-dose albendazole was as effective as triple-dose mebendazole in treating trichuriasis. 
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INTRODUCTION 
Trichuriasis is a helminth infection caused by the soil-transmitted 
helminth (STH), Trichuris trichiura. This disease is a community 
health problem, especially in areas where poverty is prevalent, along 
with a low socioeconomic status and unhealthy hygiene habits [1, 2]. 
In the Sumba Barat Daya District, Indonesia, the prevalence of 
trichuriasis is as high as 64%, and the disease is of great concern 
throughout Indonesia [3, 4]. 
T. trichiura lives in the colon, specifically in the caecum where it 
threads itself into the colonic mucosa and ingests superficial tissue 
leading to tissue injury and bleeding. The worm inserts its cephalic 
portion into the intestine, which then irritates and initiates 
inflammatory reactions of the mucosa. These events can be 
asymptomatic, but can also manifest as anorexia, epigastric pain, 
nausea, vomiting, diarrhea, bloating, and frequent flatulation. In the 
case of severe infection, the feces may contain blood and mucus, 
thus causing anemia and dysentery syndrome when untreated. It 
may also lead to rectal prolapse due to hard straining during 
defecation. In cases of chronic infection, T. trichiura can result in 
malnutrition, stunting, and cognitive problems [1]. 
Because of the high prevalence of trichuriasis and the severe impact 
of chronic infection, the World Health Organization (WHO) 
[5]recommends the administration of a single-dose of 400 mg 
albendazole or 500 mg mebendazole every six months in areas with 
a trichuriasis prevalence over 50% and once a year, if the prevalence 
increases 20%. However, both drugs possess low effectiveness 
against trichuriasis (30%). 
Even with current drug development, treating trichuriasis is very 
challenging, as there is no drug with a high effectiveness in killing T. 
trichiura. A single-dose of 400 mg albendazole and 500 mg 
mebendazole only results in a 30–50% cure rate (CR). The CR can be 
increased by giving triple doses (three days in a row) of albendazole 
and mebendazole [6]. Some studies have reported that the 
effectiveness of triple-dose mebendazole was better than triple-dose 
albendazole, although the results were not consistent between the 
studies [7, 8]. Therefore, it is necessary to investigate further the 
effectiveness of a triple dose of 400 mg albendazole and 500 mg 
mebendazole against trichuriasis. 
MATERIALS AND METHODS 
This study was approved by the Ethical Committee on Health Research, 
Faculty of Medicine, Universitas Indonesia (protocol No. 626/UN2. 
F1/ETIK/V/2018). We conducted a randomized controlled trial (RCT) 
that was preceded by a cross-sectional study to determine the 
prevalence of trichuriasis. The study was conducted at a primary 
school in Panimbang Village, Pandeglang District, Banten Province 
(total sampling), and data were collected in July–August 2018. The 
subjects’ characteristics, the prevalence of trichuriasis, intensity of 
infection, CR, and egg reduction rate (ERR) were recorded. 
Subjects were children aged 6–12 y who tested positive for T. 
trichiura eggs based on fecal examination. Parents consented to their 
children’s participation in this study. Children with fever were 
excluded. To determine the necessary number of study subjects, 
screening of trichuriasis prevalence was performed, and the number 
was calculated based on the formula:  
n =




1,962 × 0,54 × 0,46
0,052
= 382 
P: Prevalence of trichuriasis: 54% (determined from a cross-
sectional study in Perokonda Village, Sumba Barat Daya District) 
Q: 1-P 
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d: Precision rate: 5% 
Confidence interval: 95% with α = 0.05 and Zα = 1.96 
Based on the sample calculation, 382 subjects were required to 
determine the prevalence of trichuriasis. To determine the 
effectiveness of albendazole compared with mebendazole, subjects 
were selected from a cross-sectional survey, as stated above. The 
number of subjects needed for the RCT was calculated by the formula:  
n1 = n2 =




[1,96�2(0,46 x 0,54) + 0,842�(0,3 x 0,7) + (0,62 x 0,38)]2
(0,3 − 0,62)2
= 37  
Zα: Z value for type I error risk (1.96 for α = 0.05) 
Zβ: Z value for type II error risk (0.842 for β = 0.80, two-tailed) 
P1: CR of the albendazole-treated group (30%) 
P2: CR of the mebendazole-treated group (62%) 
n: number of subjects per group 
P: ½ (P1 + P2) 
Based on the calculation above, 37 subjects were assigned to each 
group. Subjects were chosen by simple random sampling method, 
then the selected subjects were randomly separated into two 
groups: the first group received a triple dose of 400 mg albendazole, 
and the second group received a triple dose 500 mg mebendazole. 
The study was single-blinded as stool examiners remained unaware 
of the grouping or treatment of the subjects. 
Data collection 
Subjects and their parents were given information about the study, 
and informed consent was obtained from the parents. Each subject 
was given a 10 ml plastic container with a label of their identity. 
Subjects’ parents were asked to fill the plastic container with the 
subjects’ feces and to return it the following day for macroscopic 
examination (color and consistency) and slide preparation using the 
Kato–Katz method. The preparation was examined microscopically 
to identify worm eggs and intensity of infection. Subjects with a 
positive stool were given a triple dose of either 400 mg albendazole 
or 500 mg mebendazole based on the assigned group. Fecal 
examination was conducted again 14 d after treatment to calculate 
CR and ERR. 
Data analysis 
The proportions of trichuriasis infection and eggs per gram (EPG) 
before and after intervention were analyzed with McNemar’s test 
and the Wilcoxon test, respectively. CR was analyzed using Fischer’s 
exact test, and ERR was analyzed using the Mann–Whitney test. All 
data were analyzed with SPSS statistical software version 20.0. 
RESULTS 
Table 1 shows the subjects’ characteristics based on gender and age. 
Girls are shown to have a higher proportion of trichuriasis, 
ascariasis, and mixed infection (trichuriasis + ascariasis). However, 
regarding the proportion of infection, there is no significant gender 
difference. Furthermore, subjects were divided into two age 
categories; 7–9 y old and 10–12 y old. Older children had a higher 
proportion of trichuriasis and mixed infection, but the proportion of 
ascariasis infection was the same. 
 
Table 1: Characteristics of the subjects (n = 382) 
Characteristics Mixed Infection T. trichiura A. lumbricoides 
Gender    
Male (n = 183) 70 (38.3%) 46 (25.1%) 45 (24.6%) 
Female (n = 199) 89 (44.7%) 51 (25.6%) 69 (34.7%) 
Chi squared test, P 0.200 0.912 0.031 
Age (years)    
7–9 (n = 162) 68 (42.0%) 36 (22.2%) 57 (35.2%) 
10–12 (n = 220) 91 (41.4%) 61 (27.7%) 57 (25.9%) 
Chi squared test, P 0.905 0.222 0.051 
Total (n = 382) 159 (41.6%) 97 (25.4%) 114 (29.8%) 
 
Based on sample size calculation, the trichuriasis subjects were 
divided equally into two groups, each group consisting of 37 
subjects. The minimum sample size for both groups was thus 74 
subjects. However, because the number of children who fulfilled 
the study criteria was 97, all subjects were included in this study 
and divided into an albendazole-treated group (n = 48) and a 
mebendazole-treated group (n = 49). All subjects in the 
albendazole group had a light infection, while in the mebendazole 
group, two subjects had a moderate infection, and the others 
mostly had mild infections. Criteria intensity of infection above are 
following WHO [6]. 
After intervention, seven subjects (14.6%) in the albendazole-treated 
group and two subjects (4.1%) in the mebendazole-treated group still 
tested positive for T. trichiura eggs. Both groups showed a significant 
reduction in the proportion with infection and mean EPG, although the 
reduction was greater in the mebendazole-treated group. There was a 
significant reduction in mean EPG in both groups (table 2). 
 
Table 2: Proportion and mean EPG of trichuriasis before and after intervention 
 Albendazole Mebendazole 












EPG    
Before, median (min–max) 84 (24–768) 96 (24–8520) 
After, median (min–max) 0 (0–48) 0 (0–48) 
Wilcoxon test, P <0.001 <0.001 
 
Table 3 presents the CR and ERR of T. trichiura after albendazole and 
mebendazole treatment. Both drugs have a high CR; mebendazole has a 
higher CR compared with albendazole, but there is no significant 
difference in CR between the two drugs. The ERR values of both drugs 
are similar, with no significant difference between them. 
During treatment, there were three adverse reactions: one allergic 
reaction in the form of urticaria in one subject in the albendazole 
group, generalized edema in two subjects in the mebendazole group, 
and the passage of worms from the mouth in four subjects in the 
mebendazole group. 
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Table 3: Cure rate (CR) and egg reduction rate (ERR) of T. trichiura after treatment 
 Albendazole Mebendazole RR (95% CI) P 
CR 85.4% 95.9% 0.891 (0.782–1.015) 0.091* 
ERR, mean ± SD 96.1 ± 15.1% 99.2 ± 3.6%  0.161** 
*Fisher’s exact test, **independent t test. 
 
DISCUSSION 
This study evaluated the effectiveness of triple-dose mebendazole 
and albendazole in the treatment of trichuriasis. At baseline, 
trichuriasis was not the only parasitic infection found; ascariasis and 
mixed infection were also present. This is understandable, given that 
the study location is one of the most prevalent areas of soil-
transmitted helminth (STH) infections. [3] It was found that girls 
had a higher proportion of STH infection compared with boys in all 
types of infection. This finding accords with a study in Kenyan 
school-aged children, in which females had a higher proportion of 
infection than males.[9] Furthermore, in the present study, older 
children (10–12 y) had a higher proportion of trichuriasis and mixed 
worm infection, but not of ascariasis infection. This is also 
comparable with a study in Ethiopia that found that as children age, 
the prevalence of infection increases. [10] However, all types of 
worm infection showed no significant age or gender differences. 
In this study, both triple-dose albendazole and mebendazole 
treatment significantly reduced the proportion of trichuriasis. In the 
albendazole-treated group, the proportion was reduced significantly 
by 85.4% (from 100% at baseline) to 14.6% after treatment. A 
greater reduction was observed in the mebendazole-treated group 
in which the proportion was significantly lowered by over 90% 
(from 100% at baseline) to 4.7% after intervention. These results 
are similar to those reported by Steinmann et al. [7], although we 
found a greater reduction in the proportion of the disease for both 
drugs in our study. Mebendazole was found to be the better 
treatment compared with albendazole, although both agents showed 
effectiveness in treating trichuriasis. 
Mebendazole is more effective in treating trichuriasis because of its 
greater reduction in the number of EPG despite a higher EPG load at 
baseline; that said, both drugs were effective in reducing the number 
of EPG significantly. This result is comparable with results from a 
study that also showed a better reduction in the number of EPG with 
mebendazole compared with albendazole, irrespective of dosage 
(single or triple dose) [7]. A study in Ethiopian schoolchildren 
showed that triple-dose mebendazole yielded higher CR and ERR 
compared with single-dose albendazole [11]. A combination therapy 
using other anthelmintic agents such as ivermectin also 
demonstrated that combination with mebendazole resulted in 
higher EPG reduction compared with albendazole [12]. 
In this study, the CR of albendazole was 85.4% and that of 
mebendazole was 95.2%, and the ERR of both drugs was similar 
(albendazole, 96%; mebendazole, 99%). Previous studies have also 
reported similar values, which supports the superiority of 
mebendazole compared with albendazole [7, 12]. 
Interestingly, because there was no significant difference in CR and 
ERR between the two agents, both drugs can be considered effective 
in treating trichuriasis. A systematic review reported that 
mebendazole achieved both the highest CR and ERR [19]. Head-to-
head regression analysis of CR and ERR differences between 
albendazole and mebendazole treatment of trichuriasis showed that 
mebendazole was superior to albendazole [13]. 
In this study, there were three adverse events in the form of allergic 
reactions (two subjects in the mebendazole group; one subject in 
albendazole group). In the mebendazole group, the allergic reaction 
was generalized urticaria, which had been previously reported as an 
adverse event, but it is not the most common one [12]. Seven 
children experienced the passage of adult worms from their mouths 
(four in the mebendazole group and three in the albendazole group). 
It is crucial to better understand the effectiveness of treatment 
strategies against trichuriasis because it has been shown that 
trichuriasis infection can affect children’s growth and school 
performance [14]. Another study in Honduras revealed that 
trichuriasis can lead to anemia, malnutrition, and ultimately growth 
retardation [15]. Therefore, treating the parasitic infection in 
children must be prioritized and given special attention, as it affects 
the future generation of a country. 
CONCLUSION 
Triple-dose albendazole and mebendazole are both equally effective 
in treating school-aged children with trichuriasis. Both groups 
showed a high CR (mebendazole, 95.2%; albendazole, 85.4%) and a 
high ERR (mebendazole, 99%; albendazole, 96%). 
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